![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » JENBURKT PHARMACEUTICALS APPROVES DECLARATION OF 10%DIVIDEND
JENBURKT PHARMACEUTICALS APPROVES DECLARATION OF 10%DIVIDEND
August 30, 2005
Jenburkt Pharmaceuticals (Q, N,C,F)* Ltd members have approved declaration of dividend of 10 per cent that is Re 1.00 per share on equity shares of Rs 10 paid up, for the year ended March 31, 2005. The board re-appoints Hardsad N Bhuta and Hemendra N Bhuta, as directors of the company, liable to retire by rotation. The company may exceed the aggregate of the paid up capital of the company and its free reserves, that is to say reserves not set apart for any specific purpose, provided that the total amount so borrowed by the board of directors and outstanding at any time shall not exceed a sum of Rs 10 crore only.
Myiris (http://www.myiris.com/newsCentre/newsPopup.php?fileR=20050830153602002&dir=2005/08/30&secID=livenews)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct